USPages > Business Directory > Major Drugs > Johnson & Johnson

Johnson & Johnson

Industry: Major Drugs

Fortune Rank: 33

For the nine months ended 30 September 2005, Johnson & Johnson's revenues increased 10% to $37.9B. Net income for the period increased 13% to $8.23B. Revenues reflect a positive impact of currency fluctuations and strong sales performance in worldwide Medical Devices and Diagnostics and Consumer segments. Higher net income reflects favorable product mix, cost improvement initiatives, and higher net interest income.

Johnson & Johnson is engaged in the manufacture and sale of a range of products in the healthcare field. Johnson & Johnson has over 200 subsidiaries that conduct business worldwide. The Company focuses in products related to human health and well being. Johnson & Johnson is organized on the principle of decentralized management. The Company's operations are categorized into Consumer, Pharmaceutical and Medical Devices and Diagnostics. The international business of Johnson & Johnson is conducted by subsidiaries located in 56 countries outside the United States. Sales of the Company's two largest products, PROCRIT and RISPERDAL, each accounted for over 5% of Johnson & Johnson's total revenues during the fiscal year ended January 2, 2005 (fiscal 2004).

Johnson & Johnson

Johnson & Johnson is a Fortune 500 company. In 2010 Johnson & Johnson was ranked number 33 on the Fortune 500 list, making it the 33rd largest company in the United States when judged by revenue.

Johnson & Johnson achieved revenue of $61,897.00 million in 2010 and earned a profit of $12,266.00 million.

Johnson & Johnson's rank changes

The company's ranking in 2010 was a decline from 2009 when it was ranked 29th on the Fortune 500. The Previous ranking was based on its 2009 revenue of $63,747 million (a change of -2 million compared to 2010) and profits of $12,949 million (a change of 0 million compared to 2010).

Another point of view

To many investors, profits are more important than the revenue a company earns. If the Fortune 500 was ranked by profits instead of revenue then Johnson & Johnson would be ranked 10th rather than 33rd due to its profits of $12,266 in 2010.

* US$ Million

• Address
  • Johnson & Johnson
    One Johnson & Johnson Plaza
    New Brunswick
    NJ
    08933
• Contact Details
  • Phone: 732-524-0400
  • Fax: 732-214-0332
  • Website: www.jnj.com
  • Stock Symbol: JNJ

• Next Page: the 34th ranked company State Farm Insurance
• Previous Page: the 32nd ranked company Walgreen Company